Remdesivir For COVID-19 Patients To Be Sold As Remdac At Rs 2,800 Per Vial


Remdesivir has been launched under the brand name Remdac in the Indian market. Meant to treat patients suffering from severe symptoms of COVID-19, it will be priced at Rs 2,800 per 100 mg vial.

Remdac is the most economical Remdesivir brand in India, the manufacturing company Zydus Cadila was quoted as saying by Hindustan Times (HT).

The company said the drug will be made available across India through the group’s strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.

“Remdac is the most affordable drug as we would like to enable patients to have access to this critical drug in the treatment of Covid-19,” Cadila Healthcare Managing Director Dr. Sharvil Patel was quoted as saying by HT. 

Get real time updates directly on you device, subscribe now.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.